Source: By RimmaKhaz - Own work, CC BY 4.0, https://commons.wikimedia.org/w/index.php?curid=79132972
Bacteria's role in gut health has received a lot of attention in recent years. But new research led by scientists at University of Utah Health shows that fungi -- another microorganism that lives within us -- may be equally important in health and disease.
Fungi thrive in the healthy gut, but they can also cause intestinal damage that may contribute to inflammatory bowel disease (IBD). Experiments with mice show that normally, the immune system keeps fungi in check, targeting the microbe when it switches into a state that can cause harm. When the system is off-balance, disease is more likely to occur.
These insights open new avenues for developing therapeutics to improve gut health. The study shows proof of concept that, one day, vaccines could be used to curb gastrointestinal disease by enhancing natural immune responses that encourage a healthy balance of fungi and other gut microbiota.
To dig deeper, her team searched for the trigger of the immune response. Working with patient samples and carrying out tests with mice, they determined that the yeast Candida albicans -- one of the main species of fungi that reside in the human gut -- elicited the strongest immune response. Further investigation showed that antibodies zeroed in on elongated fungal cell types called hyphae, specifically binding to proteins called adhesins that help microbes stick to surfaces and become invasive.
With this target in hand, the researchers could more definitively probe the fungi's role in gut health. They found that mice populated with the yeast in its normal, rounded state remained healthy. In contrast, mice populated with Candida in its invasive form caused intestinal damage that resembled IBD. The results show that normal antibody responses in the gut inhibit disease by recognizing the harmful, hyphal form of fungi.
IBD isn't the only health condition associated with fungi. Another is vaginal yeast infections. The researchers determined that a vaccine being investigated as a remedy for yeast infection triggered an immune reaction against adhesin proteins that is similar to the reaction in Crohn's patients. When inoculated with the vaccine, mice normally prone to an IBD-like condition were less likely to develop disease.
The researchers are now investigating whether vaccines could help mitigate IBD in people -- and whether the same approach can be applied more broadly to shape other microbial communities in the gut. "We aim to exploit interactions with commensal microbes and the host immune system to harness microbial products for therapies," Round says.
In addition to implications for disease, the findings also suggest fungi may be important in the healthy gut. Typically, the immune system's job is to clear infections by getting rid of invasive organisms. In this case, fungi benefit from their interaction with antibodies. The immune reaction prods fungi from their invasive state into their rounded, budding state, which improves their survival in the gut.
Journal Reference:
Kyla S. Ost, Teresa R. O’Meara, W. Zac Stephens, Tyson Chiaro, Haoyang Zhou, Jourdan Penman, Rickesha Bell, Jason R. Catanzaro, Deguang Song, Shakti Singh, Daniel H. Call, Elizabeth Hwang-Wong, Kimberly E. Hanson, John F. Valentine, Kenneth A. Christensen, Ryan M. O’Connell, Brendan Cormack, Ashraf S. Ibrahim, Noah W. Palm, Suzanne M. Noble, June L. Round. Adaptive immunity induces mutualism between commensal eukaryotes. Nature, 2021; DOI: 10.1038/s41586-021-03722-w
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
No comments:
Post a Comment
Pharmaceutical Microbiology Resources